CLINICAL_TRIALS
research
· 2024-12-02
Clinical Trial Update: Riluzole in Patients With Spinocerebellar Ataxia Type 7 [Phase 2, Phase 3]
Summary
A phase 2/3 clinical trial evaluating riluzole in patients with Spinocerebellar ataxia type 7 is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: S. Andrea Hospital | Conditions: SCA7 | Phase 2, Phase 3 | Status: RECRUITING